Roselabs Finance Ltd
Roselabs Finance Ltd (ROSELABS) last reported results for the quarter ended Jun 2026, with sales of ₹0 crore and net profit of ₹-0.05 crore. The stock last traded at ₹20, a market capitalisation of ₹20 crore. Over the past 52 weeks the stock has ranged between ₹17.9 and ₹34.4. Figures are as of 6 Oct 2026 and are not real time.
Roselabs Finance Ltd share price and key metrics
- Current price
- ₹20
- Market cap
- ₹20 cr
- Book value
- ₹-5.03
- ROE
- %
- ROCE
- -167%
- Dividend yield
- 0.00%
- 52w high / low
- 34.4/17.9
Metrics as of 6 Oct 2026. Not real time.
Track Roselabs Finance Ltd
Cruxal reads every Roselabs Finance Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Roselabs Finance Ltd growth and returns
- 10 Years
- -17%
- 5 Years
- 50%
- 3 Years
- %
- TTM
- 70%
- 10 Years
- 6%
- 5 Years
- %
- 3 Years
- 13%
- TTM
- -3%
- 10 Years
- -10%
- 5 Years
- -6%
- 3 Years
- -2%
- 1 Year
- -34%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- Last Year
- %
Roselabs Finance Ltd quarterly results
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0.71 | 0 | 0 | 1.21 | 0 | 0 |
| Expenses | 0.1 | 0.11 | 0.76 | 0.05 | 0.06 | 1.25 | 0.05 | 0.05 |
| Operating profit | -0.1 | -0.11 | -0.05 | -0.05 | -0.06 | -0.04 | -0.05 | -0.05 |
| OPM % | — | — | -7.04% | — | — | -3.31% | — | — |
| Other income | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -0.09 | -0.11 | -0.05 | -0.05 | -0.06 | -0.04 | -0.05 | -0.05 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 220.00% | 0.00% |
| Net profit | -0.09 | -0.11 | -0.05 | -0.05 | -0.06 | -0.04 | -0.16 | -0.05 |
| EPS (₹) | -0.09 | -0.11 | -0.05 | -0.05 | -0.06 | -0.04 | -0.16 | -0.05 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Roselabs Finance Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.38 | 3.03 | 0 | 0 | 0.16 | 0 | 0 | 1.14 | 0.71 | 1.21 | 1.21 |
| Operating profit | 0.51 | 0.2 | -0.29 | -0.14 | 0 | -0.44 | -0.69 | -0.17 | -0.31 | -0.2 | -0.2 |
| OPM % | 21.43% | 6.60% | — | — | 0.00% | — | — | -14.91% | -43.66% | -16.53% | -16.53% |
| Net profit | -1.43 | -0.43 | -0.39 | -0.14 | -2.57 | -0.44 | 2.02 | -0.13 | -0.29 | -0.31 | -0.31 |
| EPS (₹) | -1.43 | -0.43 | -0.39 | -0.14 | -2.57 | -0.44 | 2.02 | -0.13 | -0.29 | -0.31 | -0.31 |
TTM is the trailing twelve months to the most recent quarter.
Roselabs Finance Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Reserves | -12.81 | -12.79 | -13.18 | -13.31 | -15.88 | -16.32 | -14.30 | -14.44 | -14.73 | -15.03 |
| Borrowings | 28.54 | 7.38 | 4.08 | 4.49 | 4.57 | 4.93 | 4.33 | 4.57 | 4.93 | 5.07 |
| Other liabilities | 3.42 | 2.54 | 0.32 | 0.01 | 1.51 | 1.58 | 0.08 | 1.39 | 0.03 | 0.02 |
| Total liabilities | 29.15 | 7.13 | 1.22 | 1.19 | 0.20 | 0.19 | 0.11 | 1.52 | 0.23 | 0.06 |
| Fixed assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other assets | 29.15 | 7.13 | 1.22 | 1.19 | 0.20 | 0.19 | 0.11 | 1.52 | 0.23 | 0.06 |
| Total assets | 29.15 | 7.13 | 1.22 | 1.19 | 0.20 | 0.19 | 0.11 | 1.52 | 0.23 | 0.06 |
As reported by the company. Total assets equal total liabilities by construction.
Roselabs Finance Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -5.66 | 23.11 | -0.50 | -0.42 | -0.20 | -0.38 | 0.58 | -0.18 | -0.32 | -0.20 |
| Cash from investing | 0.00 | 0.00 | 0.00 | 0.00 | 0.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from financing | 5.99 | -23.65 | 0.05 | 0.42 | 0.07 | 0.36 | -0.60 | 0.24 | 0.37 | 0.14 |
| Net cash flow | 0.33 | -0.54 | -0.45 | 0.00 | 0.04 | -0.02 | -0.02 | 0.06 | 0.05 | -0.06 |
| Free cash flow | -5.66 | 23.11 | -0.50 | -0.42 | -0.20 | -0.38 | 0.58 | -0.18 | -0.32 | -0.20 |
| CFO / operating profit | -1,104% | 11,595% | 83% | 300% | — | 86% | -84% | 106% | 103% | 100% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Roselabs Finance Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | 2.28% | 6.53% | -9.84% | -13.46% | — | -162.50% | -175.76% | -166.67% |
| Debtor days | 1,840.34 | 0.00 | — | — | 0.00 | 429.04 | 0.00 | 0.00 |
| Inventory days | 636.28 | 0.00 | — | — | — | — | — | — |
| Days payable | 66.59 | — | — | — | — | — | — | — |
| Cash conversion cycle | 2,410.03 | 0.00 | — | — | 0.00 | 429.04 | 0.00 | 0.00 |
| Working capital days | -2,470.65 | -863.71 | — | — | -3,467.50 | -16.01 | -10.28 | -3.02 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Roselabs Finance Ltd shareholding pattern
Promoters held 74.25% at Jun 2026, broadly unchanged since Jun 2025.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 74.25% | 74.25% | 74.25% | 74.25% | 74.25% | 74.25% | 74.25% | 74.25% |
| Public | 25.75% | 25.74% | 25.75% | 25.74% | 25.75% | 25.74% | 25.74% | 25.74% |
| No. of shareholders | 1,350 | 1,397 | 1,389 | 1,415 | 1,427 | 1,433 | 1,440 | 1,450 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Roselabs Finance Ltd corporate filings
- Regulatory approval of Scheme of Merger by Roselabs Finance Limited via NCLT, with shareholder approval secured through e-votingAGM/EGMhigh impact
Cruxal's analysis: Roselabs Finance Limited has successfully obtained NCLT approval for its merger scheme…
Read the full analysis - Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018Company Updatelow impact
- Intimation of closure of trading windowInsider Trading / SASTlow impact
- Roselabs Finance Ltd announces newspaper publication for NCLT-convened shareholder meetingCompany Updatelow impact
Cruxal's analysis: Roselabs Finance Ltd has published a newspaper advertisement regarding the NCLT-convened…
Read the full analysis - Roselabs Finance Limited concludes 32nd Annual General Meeting with all resolutions passedAGM/EGMlow impact
Cruxal's analysis: Roselabs Finance Limited has successfully concluded its 32nd Annual General Meeting held…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.